Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01254929 · ClinicalTrials.gov registry record
F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
A clinical trial of Cancer and Bone Metastases, sponsored by Seattle Nuclear Medicine.
- Completed
- Registry status
- 299
- Enrollment target
- 1
- Study location
NCT01254929: Completed study of Cancer and Bone Metastases, sponsored by Seattle Nuclear Medicine.
NCT01254929 is a study of Cancer and Bone Metastases that has completed, run by Seattle Nuclear Medicine. The registered enrollment target is 299 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01254929, a study of Cancer and Bone Metastases, has completed, sponsored by Seattle Nuclear Medicine.
- COMPLETED
- Registry status
- 299 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare 18F-Fluoride PET bone scans to traditional 99mTc-MDP bone scan to determine if one is better for diagnosing bone metastases.
Primary Outcome
Individual subjects will be reviewed 6-12 months after their bone scans, utilizing all clinical and imaging data available, to determine diagnostic accuracy of each bone scan.
Conditions Studied
Interventions
- DEVICE F-18 PET bone scan
- DEVICE Tc-99m bone scan
Study Locations (1)
Washington
- Seattle Nuclear Medicine - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2010-12 |
| Est. Completion | 2020-03 |
What the finished NCT01254929 record still lists
NCT01254929 is an observational study that tracks outcomes without assigning an intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which F-18 PET bone scan is the first listed.
NCT01254929 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01254929 about?
NCT01254929 is a clinical study titled "F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases". The purpose of this study is to compare 18F-Fluoride PET bone scans to traditional 99mTc-MDP bone scan to determine if one is better for diagnosing bone metastases.
What is the current status of trial NCT01254929?
This trial is currently completed. The enrollment target is 299 participants. The study started on 2010-12. Estimated completion is 2020-03.
What conditions does trial NCT01254929 study?
This clinical trial studies the following conditions: Cancer, Bone Metastases.
What interventions are being tested in trial NCT01254929?
The interventions under investigation include: F-18 PET bone scan (DEVICE), Tc-99m bone scan (DEVICE).
Who is sponsoring clinical trial NCT01254929?
This trial is sponsored by Seattle Nuclear Medicine, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01254929 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01254929's enrollment target sits among peer trials
299 189th of 615 higher than 427 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia